Prosecution Insights
Last updated: October 02, 2026
Application No. 18/967,458

METHODS, SYSTEMS AND DEVICES FOR PRE-OPERATIVELY PLANNED ADAPTIVE GLENOID IMPLANTS

Final Rejection §102§103
Filed
Dec 03, 2024
Priority
Nov 08, 2013 — provisional 61/901,750 +5 more
Examiner
HU, ANN M
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Stryker Corporation
OA Round
4 (Final)
68%
Grant Probability
Favorable
5-6
OA Rounds
1y 11m
Est. Remaining
89%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allowance Rate
645 granted / 952 resolved
-2.2% vs TC avg
Strong +22% interview lift
Without
With
+21.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
43 currently pending
Career history
1007
Total Applications
across all art units

Statute-Specific Performance

§101
1.3%
-38.7% vs TC avg
§103
48.1%
+8.1% vs TC avg
§102
27.0%
-13.0% vs TC avg
§112
17.7%
-22.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 952 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant's arguments filed 6/16/2026 have been fully considered but they are not persuasive. The Applicant contends that Bojarski does not disclose determining the seating comprising determining whether an amount of a back side of the virtual model of the glenoid implant that is supported by or touching the virtual model of the glenoid bone is greater than a threshold percentage. The examiner respectfully disagrees. Bojarski discloses designing and/or modifying the model’s anteroposterior dimensions to meet a desired threshold value of the implant’s coverage over the bone (paras. 0185, 0317, 0324, 0415-0419, 0421-0424, 0457, 0492). This ensures that the back or posterior side of the implant model is supported by or in contact coverage with a threshold level of the model of the bone. In view of these disclosures by Bojarski, the 35 U.S.C. 102(a)(1) rejections have been maintained, as described below. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 36-39, 41-42, 44-45, and 56-57 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Bojarski et al. (Pub. No.: US 2011/0029093 A1; hereinafter “Bojarksi”). Bojarksi discloses the following regarding claim 36: a computing system comprising: memory storing computer executable instructions (paras. 0211, 0426-0432, known to be inherent computer components); and one or more processors (paras. 0211, 0426-0432, known to be inherent computer components) configured to: generate a virtual model of a glenoid bone of a patient and a virtual model of a glenoid implant (paras. 0286, 0303-0304, 0310); send instructions to an output device (e.g., computer monitor or display screen) of a user to cause the output device to display the virtual model of the glenoid implant with respect to the virtual model of the glenoid bone (paras. 0286, 0303-0304, 0310); perform virtual pre-operative analysis based on one or more of user input of the user or execution of the computer executable instructions to adjust the virtual model of the glenoid implant, wherein to adjust the virtual model of the glenoid implant (paras. 0231-0234, 0271-0272, 0281-0291, 0310-0312, 0328-0329, 0357-0360, 0419-0429), the one or more processors are configured to: adjust a placement of the virtual model of the glenoid implant with respect to the virtual model of the glenoid bone (paras. 0231-0234, 0271-0272, 0281-0294, 0357-0360, 0419-0429); evaluate bone support based on the virtual model of the glenoid implant with respect to the virtual model of the glenoid bone by determining a seating of the virtual model of the glenoid implant with respect to the virtual model of the glenoid bone (paras. 0231-0234, 0271-0272, 0281-0294, 0357-0360, 0419-0429, 0435-0439), wherein determining the seating comprises determining whether an amount of a back side of the virtual model of the glenoid implant that is supported by or touching the virtual model of the glenoid bone is greater than a threshold percentage (paras. 0185, 0317, 0324, 0415-0419, 0421-0424, 0457, 0492); and based on evaluating the bone support, adjust a geometry of the virtual model of the glenoid implant (paras. 0231-0234, 0271-0272, 0281-0294, 0357-0360, 0419-0429), and generate a model of a final glenoid implant for the patient based on the virtual pre-operative analysis (paras. 0231-0234, 0271-0272, 0281-0294, 0357-0360, 0419-0429). Bojarksi discloses the following regarding claim 37: the system of claim 36, wherein to perform the virtual pre-operative analysis, the one or more processors are configured to send instructions to the output device of the user to display simulations of one or more adjustments to the virtual model of the glenoid implant, the one or more adjustments corresponding to the one or more of the user input of the user or the execution of the computer executable instructions (paras. 0231-0234, 0271-0272, 0281-0294, 0310, 0357-0360, 0419-0429). Bojarksi discloses the following regarding claim 38: the system of claim 36, wherein to generate the virtual model of the glenoid bone, the one or more processors are configured to generate the virtual model of the glenoid bone based on images taken of the glenoid bone of the patient (paras. 0281-0294). Bojarksi discloses the following regarding claim 39: the system of claim 36, wherein the virtual model of the glenoid bone and the virtual model of the glenoid implant comprise three dimensional (3D) virtual models (paras. 0310-0312). Bojarksi discloses the following regarding claim 41: the system of claim 36, wherein to adjust the placement of the virtual model of the glenoid implant with respect to the virtual model of the glenoid bone, the one or more processors are configured to one or more of: align the virtual model of the glenoid implant with the virtual model of the glenoid bone; or adjust a medialization of the virtual model of the glenoid implant with respect to the virtual model of the glenoid bone (paras. 0231-0234, 0271-0272, 0281-0294, 0357-0360, 0419-0429, 0435-0439). Bojarksi discloses the following regarding claim 42: the system of claim 36, wherein to adjust the geometry of the virtual model of the glenoid implant, the one or more processors are configured to adjust a width of the virtual model of the glenoid implant (paras. 0211, 0214). Bojarksi discloses the following regarding claim 44: the system of claim 36, wherein the one or more processors are further configured to select a size of the virtual model of the glenoid implant from a range of sizes based on the one or more of the user input of the user or the execution of the computer executable instructions (paras. 0210-0216, 0231, 0377-0379, 0463). Bojarksi discloses the following regarding claim 45: the system of claim 36, wherein the one or more processors are further configured to: generate a virtual model of one of a natural humeral head or a humeral head implant; and send instructions to the output device of the user to cause the output device to display the virtual model of the one of the natural humeral head or the humeral head implant with respect to the virtual model of the glenoid implant (paras. 0231-0234, 0271-0272, 0281-0294, 0310, 0357-0360, 0377-0379, 0419-0429). Bojarksi discloses the following regarding claim 56: a computing system comprising: memory storing computer executable instructions (paras. 0211, 0426-0432, known to be inherent computer components); and one or more processors (paras. 0211, 0426-0432, known to be inherent computer components) configured to: generate a virtual model of a glenoid bone of a patient and a virtual model of a glenoid implant (paras. 0286, 0303-0304, 0310); send instructions to an output device (e.g., computer monitor or display screen) of a user to cause the output device to display the virtual model of the glenoid implant with respect to the virtual model of the glenoid bone (paras. 0286, 0303-0304, 0310); perform virtual pre-operative analysis based on one or more of user input of the user or execution of the computer executable instructions to adjust the virtual model of the glenoid implant, wherein to adjust the virtual model of the glenoid implant (paras. 0231-0234, 0271-0272, 0281-0291, 0310-0312, 0328-0329, 0357-0360, 0419-0429), the one or more processors are configured to: evaluate bone support based on the virtual model of the glenoid implant with respect to the virtual model of the glenoid bone by determining a seating of the virtual model of the glenoid implant with respect to the virtual model of the glenoid bone (paras. 0231-0234, 0271-0272, 0281-0294, 0357-0360, 0419-0429, 0435-0439), wherein determining the seating comprises determining whether an amount of a back side of the virtual model of the glenoid implant that is supported by or touching the virtual model of the glenoid bone is greater than a threshold percentage (paras. 0185, 0317, 0324, 0415-0419, 0421-0424, 0457, 0492); and based on evaluating the bone support, adjust a geometry of the virtual model of the glenoid implant (paras. 0231-0234, 0271-0272, 0281-0294, 0357-0360, 0419-0429); and generate a model of a final glenoid implant for the patient based on the virtual pre-operative analysis (paras. 0231-0234, 0271-0272, 0281-0294, 0357-0360, 0419-0429). Bojarksi discloses the following regarding claim 57: the computing system of claim 36, wherein the model of the final glenoid implant comprises: a virtual model of the final glenoid implant; or a physical model of the final glenoid implant (paras. 0231-0234, 0271-0272, 0281-0294, 0357-0360, 0419-0429). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 43 is/are rejected under 35 U.S.C. 103 as being unpatentable over Bojarski in view of Bojarski et al. (Pub. No. US 2011/0071802 A1; hereinafter “the ‘802 reference”). Bojarski discloses the limitations of the claimed invention, as described above. However, it does not explicitly recite adjusting a retroversion of the virtual model of the glenoid implant; or adjust an inferior tilt of the virtual model of the glenoid implant. The ‘802 reference teaches that adjusting the geometry of the virtual model of the implant comprises adjusting a retroversion of the virtual model of the glenoid implant; or adjusting an inferior tilt of the virtual model of the glenoid implant (paras. 0012, 0057, 0070, 0111-0126), for the purpose of ensuring that the implant will properly fit its implantation site. It would have been obvious to one having ordinary skill in the art to adjust features of the models of Bojarski, according to the teachings of the ‘802 reference, in order to ensure that the implant will properly fit a particular patient's anatomy. Such a modification would be made with a reasonable expectation of success. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Ann Hu whose telephone number is (571) 272-6652. The examiner can normally be reached on Monday-Friday (9:00 am-5:30 pm EST). If attempts to reach the examiner by telephone are unsuccessful, please contact the examiner’s supervisor, Jerrah Edwards, at (408) 918-7557. The fax phone number for the organization where this application or proceeding is assigned is (571) 273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ANN HU/Primary Examiner, Art Unit 3774
Read full office action

Prosecution Timeline

Show 8 earlier events
Oct 16, 2025
Response after Non-Final Action
Nov 17, 2025
Request for Continued Examination
Dec 02, 2025
Response after Non-Final Action
Mar 16, 2026
Non-Final Rejection mailed — §102, §103
Jun 04, 2026
Examiner Interview Summary
Jun 04, 2026
Applicant Interview (Telephonic)
Jun 16, 2026
Response Filed
Aug 17, 2026
Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746120
CONTROLLABLY DEPLOYABLE PROSTHETIC VALVE
3y 7m to grant Granted Sep 29, 2026
Patent 12746307
CARTILAGE TREATMENT FOR USE IN EYELID RECONSTRUCTION
2y 11m to grant Granted Sep 29, 2026
Patent 12740868
MEDIALLY STABILISING KNEE ENDOPROSTHESIS
2y 8m to grant Granted Sep 22, 2026
Patent 12727993
EXPANDABLE SEALING SKIRT TECHNOLOGY FOR LEAK-PROOF ENDOVASCULAR PROSTHESES
6y 4m to grant Granted Sep 08, 2026
Patent 12727990
Temporary Keratoprosthesis, Corneal Transplant Suturing Jig, Temporary Endoprosthesis, and Method of Using
3y 4m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
68%
Grant Probability
89%
With Interview (+21.6%)
3y 9m (~1y 11m remaining)
Median Time to Grant
High
PTA Risk
Based on 952 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month